Patent ID: 9375492
Filing Date: 2016-06-28
CPC Classification: A61K,C09K,G01K

Claim Text:
1. A method of diagnosing pathological lesions of the mammary gland by means of thermography, wherein one or more temperature anomalies resulting from said pathological lesions are detected by thermography on the breast surface every 0.5° C. in the temperature range from 31.8° C. to 34.8° C., beginning at 31.8° C. and divided into three sub-ranges: from 31.8° C. to 32.8° C., from 32.8° C. to 33.8° C. and from 33.8° C. to 34.8° C., wherein the temperature detection is carried out using three liquid-crystal mixtures able to form a thermooptically active mesophase every 0.5° C. in the three temperature ranges from 31.8° C. to 32.8° C., from 32.8° C. to 33.8° C. and from 33.8° C. to 34.8° C., wherein the first mixture forms thermooptically active mesophase in the temperature range from 31.8° C. to 32.8° C. and the first mixture consists of 48.61% by weight cholesteryl pelargonate, 50.39% by weight cholesteryl oleyl carbonate, 0.28% by weight cholesterol propionate, 0.20% by weight cholesterol chloride and 0.52% by weight 4,4′-dipentylazoxybenzene, the second mixture forms thermooptically active mesophase in the temperature range from 32.8° C. to 33.8° C. and the second mixture consists of 50.28% by weight cholesteryl pelargonate, 48.72% by weight cholesteryl oleyl carbonate, 0.24% by weight cholesteryl propionate, 0.18% by weight cholesteryl chloride and 0.58% by weight 4,4′-dipentylazoxybenzene′, the third mixture forms thermooptically active mesophase in the temperature range from 33.8° C. to 34.8° C. and the third mixture consists of 52.53% by weight cholesteryl pelargonate, 46.47% by weight cholesterol oleyl carbonate, 0.18% by weight cholesterol propionate, 0.16% by weight cholesterol chloride and 0.66% by weight 4,4′-dipentylazoxybenzene.